Product Theatres

Monoclonal Antibodies (mAbs): Three Decades of Innovation and Progress

 
Faculty:

Eli M. Roth MD, FACC, FNLA
Medical Director, Sterling Research Group
Professor of Clinical Medicine, University of Cincinnati

Where: Grand Cypress Ballroom G

When: May 2^nd, 2014 at 11:35AM-12:35PM

Brought to you by Sanofi-aventis U.S. and Regeneron Pharmaceuticals, Inc.

---

KYNAMRO®(mipomersen sodium) injection 200 mg/mL: A Review for Clinicians

Dr. Duell’s special areas of interest include lipid disorders (e.g. high cholesterol), metabolic disorders, homocysteine metabolism, prevention of atherosclerosis (heart disease), diabetes, endocrinology and management of obesity. He currently serves as the director of OHSU’s Metabolic Disorders Clinic. He received his medical degree from OHSU in 1983, and completed his Medicine residency at OHSU and the University of Chicago. He completed his Metabolism, Endocrinology and Nutrition fellowship at the University of Washington in Seattle.

Staff:

P. Barton Duell, MD
Director of the Lipid Disorders Clinic
Director, Lipid-Atherosclerosis Laboratory
Director, LDL Apheresis Unit
Oregon Health and Science University

Where: Grand Cypress G

When:  Friday, May 2^nd, 2014 6:00PM-7:00PM

Brought to you by Genzyme.